Title: Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.
Journal: Journal of medicinal chemistry 20080214
Title: Pradefovir, a liver-targeted prodrug of adefovir against HBV infection.
Journal: Current opinion in investigational drugs (London, England : 2000) 20070801
Title: Metabolic activation of pradefovir by CYP3A4 and its potential as an inhibitor or inducer.
Journal: Antimicrobial agents and chemotherapy 20060901
Title: HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060201
Title: Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.
Journal: Journal of clinical pharmacology 20051101
Title: Liver-targeted drug delivery using HepDirect prodrugs.
Journal: The Journal of pharmacology and experimental therapeutics 20050201
Title: Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys.
Journal: Antiviral chemistry & chemotherapy 20041101
Title: Lin CC, et al. Metabolic activation of Pradefovir by CYP3A4 and its potential as an inhibitor or inducer. Antimicrob Agents Chemother. 2006 Sep;50(9):2926-31.